Page last updated: 2024-09-04

ivabradine and hydralazine

ivabradine has been researched along with hydralazine in 6 studies

Compound Research Comparison

Studies (ivabradine)	Trials (ivabradine)	Recent Studies (post-2010) (ivabradine)	Studies (hydralazine)	Trials (hydralazine)	Recent Studies (post-2010) (hydralazine)
1,143	197	833	4,580	364	393

Protein Interaction Comparison

Protein	Taxonomy	hydralazine (IC50)
Myeloperoxidase	Homo sapiens (human)	1.265
Polyunsaturated fatty acid lipoxygenase ALOX15	Oryctolagus cuniculus (rabbit)	3.649
Lactoperoxidase	Bos taurus (cattle)	1.2

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albajrami, O; Bellumkonda, L; Jacoby, D	1
Lim, WY; Woldman, S	1
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F	1
Adhyaru, B; Raj, L	1
Butler, J; Hamo, CE; Papadimitriou, L	1
Wu, A	1

Reviews

5 review(s) available for ivabradine and hydralazine

Article	Year
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications. British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists	2013
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Swiss medical weekly, 2016, Volume: 146 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents	2016
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF). Postgraduate medical journal, 2016, Volume: 92, Issue:1094 Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents	2016
Heart Failure Guidelines on Pharmacotherapy. Handbook of experimental pharmacology, 2017, Volume: 243 Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Diuretics; Drug Combinations; Heart Failure; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Nitrates; Practice Guidelines as Topic; Severity of Illness Index; Stroke Volume; Tetrazoles; Valsartan; Vasodilator Agents	2017
Heart Failure. Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors	2018

Other Studies

1 other study(ies) available for ivabradine and hydralazine

Article	Year
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph? Cardiology clinics, 2011, Volume: 29, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Resynchronization Therapy; Defibrillators, Implantable; Heart Failure; Heart-Assist Devices; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Nitrates; Renin-Angiotensin System; Risk Factors; Survival Analysis; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling	2011

Article

Year

Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?

Cardiology clinics, 2011, Volume: 29, Issue:4

Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiac Resynchronization Therapy; Defibrillators, Implantable; Heart Failure; Heart-Assist Devices; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Nitrates; Renin-Angiotensin System; Risk Factors; Survival Analysis; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling

2011